Pier Vitale Nuzzo

4.6k total citations
58 papers, 943 citations indexed

About

Pier Vitale Nuzzo is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Pier Vitale Nuzzo has authored 58 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 23 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Pier Vitale Nuzzo's work include Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Prostate Cancer Treatment and Research (15 papers). Pier Vitale Nuzzo is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Prostate Cancer Treatment and Research (15 papers). Pier Vitale Nuzzo collaborates with scholars based in United States, Italy and Canada. Pier Vitale Nuzzo's co-authors include Toni K. Choueiri, Amin H. Nassar, Francesco Boccardo, A. Rubagotti, Sarah Abou Alaiwi, Lauren C. Harshman, Francesco Ricci, Matthew L. Freedman, Keegan Korthauer and Sándor Spisák and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Pier Vitale Nuzzo

53 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pier Vitale Nuzzo United States	16	500	389	382	298	109	58	943
Bradley A. Hancock United States	11	214 0.4×	532 1.4×	494 1.3×	359 1.2×	50 0.5×	21	963
Seung Eun Lee South Korea	19	545 1.1×	475 1.2×	310 0.8×	239 0.8×	186 1.7×	46	1.0k
Corrine Zarwan United States	13	200 0.4×	691 1.8×	321 0.8×	214 0.7×	123 1.1×	27	1.1k
Caroline E. McCoach United States	18	1.0k 2.1×	757 1.9×	413 1.1×	383 1.3×	290 2.7×	56	1.5k
Ana M. Gonzalez‐Angulo United States	19	292 0.6×	703 1.8×	254 0.7×	528 1.8×	140 1.3×	22	1.1k
Esther Conde Spain	22	947 1.9×	582 1.5×	641 1.7×	488 1.6×	144 1.3×	51	1.5k
Dingwei Ye China	17	621 1.2×	417 1.1×	502 1.3×	286 1.0×	303 2.8×	88	1.2k
Pierre‐Alexandre Just France	17	281 0.6×	269 0.7×	415 1.1×	222 0.7×	163 1.5×	45	1.1k
Alden M. Parsons United States	10	367 0.7×	210 0.5×	302 0.8×	186 0.6×	165 1.5×	14	935
Marilyn Mulay United States	11	250 0.5×	365 0.9×	243 0.6×	104 0.3×	71 0.7×	17	644

Countries citing papers authored by Pier Vitale Nuzzo

Since Specialization

Citations

This map shows the geographic impact of Pier Vitale Nuzzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pier Vitale Nuzzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pier Vitale Nuzzo more than expected).

Fields of papers citing papers by Pier Vitale Nuzzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pier Vitale Nuzzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pier Vitale Nuzzo. The network helps show where Pier Vitale Nuzzo may publish in the future.

Co-authorship network of co-authors of Pier Vitale Nuzzo

This figure shows the co-authorship network connecting the top 25 collaborators of Pier Vitale Nuzzo. A scholar is included among the top collaborators of Pier Vitale Nuzzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pier Vitale Nuzzo. Pier Vitale Nuzzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nuzzo, Pier Vitale, et al.. (2024). Comprehensive analysis of plasma methylome reveals distinct patterns of methylation changes between responders and non-responders to neoadjuvant chemotherapy in breast cancer. SHILAP Revista de lepidopterología. 6. 100159–100159. 3 indexed citations

Nuzzo, Pier Vitale, Caroline F. Ribeiro, Silvia Rodrigues, et al.. (2024). A phase I, open-label, dose-finding study of fatty acid synthase (FASN) inhibitor TVB-2640 administered in combination with enzalutamide (Enza) in men with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 42(4_suppl). TPS248–TPS248. 1 indexed citations

Skelton, William Paul, Jonathan Thomas, Rohit Jain, et al.. (2024). Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer. 22(5). 102143–102143.

Carlino, Francesca, Raffaele Addeo, Marianna Scrima, et al.. (2024). Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation. Journal of Translational Medicine. 22(1). 938–938. 5 indexed citations

Cirmena, Gabriella, Lorenzo Ferrando, Paola Cuccarolo, et al.. (2023). Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol. Critical Reviews in Oncology/Hematology. 185. 103963–103963. 9 indexed citations

Saieva, Calogero, Richard M. Lee‐Ying, Pier Vitale Nuzzo, et al.. (2023). Efficacy and safety of docetaxel (D) vs androgen-receptor signaling inhibitors (ARSi) as second-line therapy (Rx) after progression on alternative ARSi as first-line Rx for patients who are elderly (≥75 years old) with metastatic castration-resistant prostate cancer (mCRPC) in a multicenter international database: A SPARTACUSS–Meet-URO 26 study.. Journal of Clinical Oncology. 41(6_suppl). 166–166. 1 indexed citations

Omar, Mohamed, et al.. (2023). Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. Journal of Translational Medicine. 21(1). 811–811. 3 indexed citations

Nuzzo, Pier Vitale, Elio Adib, Catherine Curran, et al.. (2022). Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors. Clinical Genitourinary Cancer. 20(4). 301–306. 17 indexed citations

Doroshow, Deborah B., Andrew Schmidt, Ziad Bakouny, et al.. (2020). LBA74 Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS). Annals of Oncology. 31. S1204–S1204. 4 indexed citations

10.

Nassar, Amin H., Lana Hamieh, Jacob E. Berchuck, et al.. (2020). Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma. Genetics in Medicine. 22(8). 1366–1373. 51 indexed citations

11.

McGregor, Bradley A., Aly‐Khan A. Lalani, Wanling Xie, et al.. (2020). Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma. European Journal of Cancer. 135. 203–210. 53 indexed citations

12.

Nassar, Amin H., Lana Hamieh, Kathryn P. Gray, et al.. (2019). Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular Cancer Therapeutics. 19(2). 690–696. 10 indexed citations

13.

Bakouny, Ziad, Natalie I. Vokes, Xīn Gào, et al.. (2019). Efficacy of immune checkpoint inhibitors (ICI) and genomic characterization of sarcomatoid and/or rhabdoid (S/R) metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 37(15_suppl). 4514–4514. 6 indexed citations

14.

Lalani, Aly‐Khan A., Ziad Bakouny, Subrina Farah, et al.. (2019). Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC). Annals of Oncology. 30. v396–v396. 4 indexed citations

15.

Cattrini, Carlo, A. Rubagotti, Pier Vitale Nuzzo, et al.. (2018). Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome. Clinical Genitourinary Cancer. 16(6). e1257–e1265. 11 indexed citations

16.

Takeda, David Y., Sándor Spisák, Ji-Heui Seo, et al.. (2018). A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer. Cell. 174(2). 422–432.e13. 202 indexed citations

17.

Nuzzo, Pier Vitale, et al.. (2016). The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome. BMC Cancer. 16(1). 95–95. 25 indexed citations

18.

Nuzzo, Pier Vitale, et al.. (2015). Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes. Annals of Oncology. 26. iii15–iii15. 1 indexed citations

19.

Nuzzo, Pier Vitale, Giulia Buzzatti, Francesco Ricci, et al.. (2014). Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer?. Clinical Genitourinary Cancer. 12(5). 301–311. 44 indexed citations

20.

Nuzzo, Pier Vitale, A. Rubagotti, Francesco Ricci, et al.. (2012). Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death. BMC Cancer. 12(1). 625–625. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact